UMD Postdoc Featured in Pharmtech on Biopharmaceutical Drug Development and Manufacturing
Wed, Sep 18, 2024
Dr. Anupreet Kaur
UMD Postdoc Anupreet Kaur, working under the direction of Dr. Robert Brinson, was recently featured in a story by PharmTech covering biopharmaceutical development and manufacturing. In the interview, Kaur highlighted how molecular and cellular biology, particularly a deeper, comprehensive understanding of monoclonal antibodies (mAbs) and antigens are revolutionizing the field of immunotherapies. She also pointed to the value of studying the interactions between different combinations of antibodies and excipients at the atomic level to better understand the molecular mechanisms that preserve the structural and functional integrity of mAbs under different formulations. She notes that such knowledge can be used to more rapidly optimize mAb performance and stability during drug formulation screening. The interview touches on current challenges in the field, including the high sensitivity of mAbs to the environment and the exploration of advanced analytical techniques. Despite these challenges, Dr. Kaur is hopeful for the field’s future trends.
